Literature DB >> 18473123

Fragmentation of a recombinant monoclonal antibody at various pH.

Georgeen Gaza-Bulseco1, Hongcheng Liu.   

Abstract

PURPOSE: To determine the relative importance of direct hydrolysis and beta-elimination, two common mechanisms of antibody hinge region fragmentation, and the impact of the conserved N-linked oligosaccharides in affecting antibody fragmentation under various pH.
METHODS: A recombinant monoclonal antibody was incubated in buffers of various pH at 40 degrees C for 5 weeks. The level of fragmentation was measured using size-exclusion-chromatography (SEC). The specific sites of fragmentation were determined by analyzing SEC fractions using liquid chromatography mass spectrometry (LC-MS).
RESULTS: Direct hydrolysis was accelerated by acidic and basic pH, while beta-elimination contributed to hinge region fragmentation at pH 7 and above. In addition, a shift of the major peptide bond hydrolysis sites in the hinge region towards the C-terminal direction with the decrease of sample pH from 9 to 5 was observed. At pH 4, the major cleavage site shifted outside the hinge region and was localized in the CH2 domain. Oligosaccharides did not affect hinge region fragmentation in the pH range of 5-9, however, at pH 4 oligosaccharides slowed down fragmentation in the CH2 domain.
CONCLUSIONS: Antibody fragmentation level, sites and mechanisms were affected by pH. Oligosaccharides only affected the rate of fragmentation at pH 4.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18473123     DOI: 10.1007/s11095-008-9606-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  31 in total

1.  Selective cleavage of human IgG by the matrix metalloproteinases, matrilysin and stromelysin.

Authors:  Andrew J H Gearing; Susan J Thorpe; Karen Miller; Matthew Mangan; Paul G Varley; Tim Dudgeon; George Ward; Christina Turner; Robin Thorpe
Journal:  Immunol Lett       Date:  2002-04-01       Impact factor: 3.685

2.  Development of an analytical reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry method for characterization of recombinant antibodies.

Authors:  Thomas M Dillon; Pavel V Bondarenko; Margaret Speed Ricci
Journal:  J Chromatogr A       Date:  2004-10-22       Impact factor: 4.759

3.  Non-enzymatic hinge region fragmentation of antibodies in solution.

Authors:  Armando J Cordoba; Bao-Jen Shyong; Deirdre Breen; Reed J Harris
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-04-25       Impact factor: 3.205

4.  Monitoring of IgG antibody thermal stability by micellar electrokinetic capillary chromatography and matrix-assisted laser desorption/ionization mass spectrometry.

Authors:  A J Alexander; D E Hughes
Journal:  Anal Chem       Date:  1995-10-15       Impact factor: 6.986

5.  Fragmentation of immunoglobulin during storage.

Authors:  G E Connell; R H Painter
Journal:  Can J Biochem       Date:  1966-03

6.  Effects of alkali on proteins. Disulfides and their products.

Authors:  A S Nashef; D T Osuga; H S Lee; A I Ahmed; J R Whitaker; R E Feeney
Journal:  J Agric Food Chem       Date:  1977 Mar-Apr       Impact factor: 5.279

7.  Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.

Authors:  M H Tao; S L Morrison
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

8.  A protein structural change in aglycosylated IgG3 correlates with loss of huFc gamma R1 and huFc gamma R111 binding and/or activation.

Authors:  J Lund; T Tanaka; N Takahashi; G Sarmay; Y Arata; R Jefferis
Journal:  Mol Immunol       Date:  1990-11       Impact factor: 4.407

9.  Proton nuclear magnetic resonance studies of the structure of the Fc fragment of human immunoglobulin G1: comparisons of native and recombinant proteins.

Authors:  H Matsuda; S Nakamura; Y Ichikawa; K Kozai; R Takano; M Nose; S Endo; Y Nishimura; Y Arata
Journal:  Mol Immunol       Date:  1990-06       Impact factor: 4.407

10.  Understanding base-assisted desulfurization using a variety of disulfide-bridged peptides.

Authors:  Amit K Galande; John O Trent; Arno F Spatola
Journal:  Biopolymers       Date:  2003       Impact factor: 2.505

View more
  20 in total

1.  The impact of glycosylation on monoclonal antibody conformation and stability.

Authors:  Kai Zheng; Christopher Bantog; Robert Bayer
Journal:  MAbs       Date:  2011-11-01       Impact factor: 5.857

2.  Effects of subclass change on the structural stability of chimeric, humanized, and human antibodies under thermal stress.

Authors:  Takahiko Ito; Kouhei Tsumoto
Journal:  Protein Sci       Date:  2013-09-30       Impact factor: 6.725

Review 3.  Fragmentation of monoclonal antibodies.

Authors:  Josef Vlasak; Roxana Ionescu
Journal:  MAbs       Date:  2011-05-01       Impact factor: 5.857

Review 4.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

5.  Uncommon Peptide Bond Cleavage of Glucagon from a Specific Vendor under near Neutral to Basic Conditions.

Authors:  Hong-Jian Zheng; Bin-Bin Shen; Jing Wang; Haibin Wang; Guo-Li Huo; Li-Rui Huang; Jian-Qing Gao; Wei-Jie Fang
Journal:  Pharm Res       Date:  2019-06-03       Impact factor: 4.200

Review 6.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

7.  Influence of glycosylation pattern on the molecular properties of monoclonal antibodies.

Authors:  Kai Zheng; Mark Yarmarkovich; Christopher Bantog; Robert Bayer; Thomas W Patapoff
Journal:  MAbs       Date:  2014-03-24       Impact factor: 5.857

Review 8.  Analytical comparability study of recombinant monoclonal antibody therapeutics.

Authors:  Alexandre Ambrogelly; Stephen Gozo; Amit Katiyar; Shara Dellatore; Yune Kune; Ram Bhat; Joanne Sun; Ning Li; Dongdong Wang; Christine Nowak; Alyssa Neill; Gomathinayagam Ponniah; Cory King; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-03-20       Impact factor: 5.857

Review 9.  Forced degradation of recombinant monoclonal antibodies: A practical guide.

Authors:  Christine Nowak; Jason K Cheung; Shara M Dellatore; Amit Katiyar; Ram Bhat; Joanne Sun; Gomathinayagam Ponniah; Alyssa Neill; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2017-08-30       Impact factor: 5.857

10.  Buffer-dependent fragmentation of a humanized full-length monoclonal antibody.

Authors:  Branden A Salinas; Hasige A Sathish; Ambarish U Shah; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2010-07       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.